Generic Drug Manufacturing & Formulation
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract entails the manufacture and formulation of generic prescription medications including antibiotics, antihypertensives, and antidiabetics to meet international pharmacopeial standards such as USP and WHO specifications, ensuring quality, potency, and safety for inclusion in the National Health Fund’s procurement pool. Production must adhere to globally recognized regulatory frameworks and maintain consistent batch-to-batch reliability to support public health initiatives in Jamaica and potentially other partner nations served by the NHF. The subcontract is open for responses until July 29, 2026, with a posting date of July 16, 2026, under NAICS code 325412 for pharmaceutical preparation manufacturing. The contracting entity is the Government of Jamaica through the National Health Fund, with no specified place of performance or point of contact provided. Interested parties must align their operations with the NHF’s requirements for scalable, cost-effective production suitable for national health programs, and ensure full compliance with all quality assurance and documentation protocols required for inclusion in a government-run pharmaceutical supply chain.
General Info
Agency
NAICS
Place of Performance
JAMSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Government of Jamaica → National Health Fund
Same awarding agency
